정신건강의학과 임상 및 연구에서 이해 상충 관련 문제
Issues of Conflict of Interest in Psychiatric Research and Practice
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
A conflict of interest is usually defined as a set of circumstances that creates a risk that professional judgments or actions regarding a primary interest will be unduly influenced by a secondary interest. In general, a conflict of interest can be classified as either a financial or a non-financial one. A financial conflict of interest reportedly occurs frequently in medical (and psychiatric) research and practice and is associated with a greater likelihood of reporting results favorable to the intervention being studied. A non-financial conflict of interest may occur in psychiatric research and practice as a result of the so-called “allegiance effect.” It is very important that clinicians and researchers in the field of psychiatry be aware that their field is vulnerable to both financial and non-financial conflicts of interest. Considering that it is impossible in modern psychiatry to be completely free from possible conflicts of interest, the best way to manage a conflict of interest is disclosure based on the principles of transparency. Actions that might lead to conflicts of interest should be avoided as much as possible. (Anxiety and Mood 2015;11(2):114-119)
Abstract
A conflict of interest is usually defined as a set of circumstances that creates a risk that professional judgments or actions regarding a primary interest will be unduly influenced by a secondary interest. In general, a conflict of interest can be classified as either a financial or a non-financial one. A financial conflict of interest reportedly occurs frequently in medical (and psychiatric) research and practice and is associated with a greater likelihood of reporting results favorable to the intervention being studied. A non-financial conflict of interest may occur in psychiatric research and practice as a result of the so-called “allegiance effect.” It is very important that clinicians and researchers in the field of psychiatry be aware that their field is vulnerable to both financial and non-financial conflicts of interest. Considering that it is impossible in modern psychiatry to be completely free from possible conflicts of interest, the best way to manage a conflict of interest is disclosure based on the principles of transparency. Actions that might lead to conflicts of interest should be avoided as much as possible. (Anxiety and Mood 2015;11(2):114-119)
참고문헌 (28)
- Thompson DF, "Understanding financial conflicts of interest", N Engl J Med, 329, pp.573~576 (1993)
- Maj M, "Conflicts of interests in psychiatric practice and research", Psychiatrie, 3, pp.138~140 (2005)
- Perlis RG, "Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry", Am J Psychiatry, 162, pp.1957~1960 (2005)
- Fava GA, "Financial conflicts of interest in psychiatry", World Psychiatry, 6, pp.19~24 (2007)
- Heres S, "Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine : an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics", Am J Psychiatry, 163, pp.185~194 (2006)
- Baker CB, "Quantitativeanalysis of sponsorshipbias in economicstudies of antidepressants", Br J Psychiatry, 183, pp.498~506 (2003)
- Steinbrook R, "Controlling conflict of interest : proposals from the Institute of Medicine", N Engl J Med, 360, pp.2160~2163 (2009)
- 이일학, "의료인-제약산업 관계의 이해상충과 윤리적 원칙", 한국의료윤리학회지, 14(2), pp.193~201 (2011), 한국의료윤리학회
- Phillips ML, "Bipolar disorder diagnosis : challenges and future directions", Lancet, 381, pp.1663~1671 (2013)
- Kuehn BM, "APA targets unnecessary antipsychotic use", JAMA, 310, pp.1909~1910 (2013)
- Lopez OL, "The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer’s disease", Am J Psychiatry, 170, pp.1051~1058 (2013)
- Carpenter WT Jr, "Decisional capacity for informed consent in schizophrenia research", Arch Gen Psychiatry, 57, pp.533~538 (2000)
- Kim SY, "Assessing the competence of persons with Alzheimer’s disease in providing informed consent for participation in research", Am J Psychiatry, 158, pp.712~717 (2001)
- Norris SL, "Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications : An observational study", BMC Med Ethics, 13, pp.24~ (2012)
- Tanne JH, "US university psychiatrist loses chairmanship over drug company payments", BMJ, 338, pp.3188~ (2009)
- Safer DJ, "Design and reporting modifications in industrysponsored comparative psychopharmacology trials", J Nerv Ment Dis, 190, pp.583~592 (2002)
- Otto MW, "Assay sensitivity, failed clinical trials and the conduct of science", Psychother Psychosom, 71, pp.241~243 (2002)
- Meier B, "Major medical journals will require registration of trials", New York Times, C11~ (2004)
- "Who.int"[URL]
- Helmchen H, "Ethics of clinical research with mentally ill persons", Eur. Arch Psychiatry Clin Neurosci, 262, pp.441~452 (2012)
- 이하영, "의약품 리베이트 자율규제의 한계: 제도론적 접근", 행정논총, 49(1), pp.139~165 (2011), 한국행정연구소
- 강명신, "의사-제약산업체 상호작용에서의 이해상충 관리", 한국의료윤리학회지, 14(3), pp.361~371 (2011), 한국의료윤리학회
- Maj M, "Financial and non-financial conflicts of interests in psychiatry", Eur. Arch. Psychiatry Clin. Neurosci, 260, pp.S147~S151 (2010)
- Maj M, "Non-financial conflicts of interests in psychiatric research and practice", Br J Psychiatry, 193, pp.91~92 (2008)
- Luborsky L, "The researcher’s own therapy allegiance : a ‘‘wild card’’ in comparisons of treatment efficacy", Clin Psychol Sci Pract, 6, pp.95~106 (1999)
- Hussain A, "Declaring financial competing interests : survey of five medical journals", BMJ, 323, pp.263~264 (2001)
- International Committee of Medical Journals Editors, "Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publications", Ann Intern Med, 126, pp.36~47 (1997)
- "Statements on Principles"[URL]